These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 34444817)

  • 1. Effect of Dietary Coenzyme Q10 Plus NADH Supplementation on Fatigue Perception and Health-Related Quality of Life in Individuals with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial.
    Castro-Marrero J; Segundo MJ; Lacasa M; Martinez-Martinez A; Sentañes RS; Alegre-Martin J
    Nutrients; 2021 Jul; 13(8):. PubMed ID: 34444817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of coenzyme Q10 plus nicotinamide adenine dinucleotide supplementation on maximum heart rate after exercise testing in chronic fatigue syndrome - A randomized, controlled, double-blind trial.
    Castro-Marrero J; Sáez-Francàs N; Segundo MJ; Calvo N; Faro M; Aliste L; Fernández de Sevilla T; Alegre J
    Clin Nutr; 2016 Aug; 35(4):826-34. PubMed ID: 26212172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does oral coenzyme Q10 plus NADH supplementation improve fatigue and biochemical parameters in chronic fatigue syndrome?
    Castro-Marrero J; Cordero MD; Segundo MJ; Sáez-Francàs N; Calvo N; Román-Malo L; Aliste L; Fernández de Sevilla T; Alegre J
    Antioxid Redox Signal; 2015 Mar; 22(8):679-85. PubMed ID: 25386668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Melatonin Plus Zinc Supplementation on Fatigue Perception in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Castro-Marrero J; Zaragozá MC; López-Vílchez I; Galmés JL; Cordobilla B; Maurel S; Domingo JC; Alegre-Martín J
    Antioxidants (Basel); 2021 Jun; 10(7):. PubMed ID: 34201806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does Coenzyme Q10 Plus Selenium Supplementation Ameliorate Clinical Outcomes by Modulating Oxidative Stress and Inflammation in Individuals with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome?
    Castro-Marrero J; Domingo JC; Cordobilla B; Ferrer R; Giralt M; Sanmartín-Sentañes R; Alegre-Martín J
    Antioxid Redox Signal; 2022 Apr; 36(10-12):729-739. PubMed ID: 35229657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary and nutrition interventions for the therapeutic treatment of chronic fatigue syndrome/myalgic encephalomyelitis: a systematic review.
    Campagnolo N; Johnston S; Collatz A; Staines D; Marshall-Gradisnik S
    J Hum Nutr Diet; 2017 Jun; 30(3):247-259. PubMed ID: 28111818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Yeast Beta-Glucan Supplementation with Multivitamins Attenuates Cognitive Impairments in Individuals with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Lacasa M; Alegre-Martin J; Sentañes RS; Varela-Sende L; Jurek J; Castro-Marrero J
    Nutrients; 2023 Oct; 15(21):. PubMed ID: 37960157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coenzyme Q10 deficiency in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is related to fatigue, autonomic and neurocognitive symptoms and is another risk factor explaining the early mortality in ME/CFS due to cardiovascular disorder.
    Maes M; Mihaylova I; Kubera M; Uytterhoeven M; Vrydags N; Bosmans E
    Neuro Endocrinol Lett; 2009; 30(4):470-6. PubMed ID: 20010505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, double-blind, placebo-controlled study of oral coenzyme Q10 to relieve self-reported treatment-related fatigue in newly diagnosed patients with breast cancer.
    Lesser GJ; Case D; Stark N; Williford S; Giguere J; Garino LA; Naughton MJ; Vitolins MZ; Lively MO; Shaw EG;
    J Support Oncol; 2013 Mar; 11(1):31-42. PubMed ID: 22682875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxaloacetate Treatment For Mental And Physical Fatigue In Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Long-COVID fatigue patients: a non-randomized controlled clinical trial.
    Cash A; Kaufman DL
    J Transl Med; 2022 Jun; 20(1):295. PubMed ID: 35764955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic effects of oral NADH on the symptoms of patients with chronic fatigue syndrome.
    Forsyth LM; Preuss HG; MacDowell AL; Chiazze L; Birkmayer GD; Bellanti JA
    Ann Allergy Asthma Immunol; 1999 Feb; 82(2):185-91. PubMed ID: 10071523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial Dysfunction and Coenzyme Q10 Supplementation in Post-Viral Fatigue Syndrome: An Overview.
    Mantle D; Hargreaves IP; Domingo JC; Castro-Marrero J
    Int J Mol Sci; 2024 Jan; 25(1):. PubMed ID: 38203745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Nicotinamide adenine dinucleotide (NADH) in patients with chronic fatigue syndrome].
    Alegre J; Rosés JM; Javierre C; Ruiz-Baqués A; Segundo MJ; de Sevilla TF
    Rev Clin Esp; 2010 Jun; 210(6):284-8. PubMed ID: 20447621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind, placebo-controlled, randomized, clinical trial of the TLR-3 agonist rintatolimod in severe cases of chronic fatigue syndrome.
    Strayer DR; Carter WA; Stouch BC; Stevens SR; Bateman L; Cimoch PJ; Lapp CW; Peterson DL; ; Mitchell WM
    PLoS One; 2012; 7(3):e31334. PubMed ID: 22431963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ubiquinol-10 supplementation improves autonomic nervous function and cognitive function in chronic fatigue syndrome.
    Fukuda S; Nojima J; Kajimoto O; Yamaguti K; Nakatomi Y; Kuratsune H; Watanabe Y
    Biofactors; 2016 Jul; 42(4):431-40. PubMed ID: 27125909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B-Lymphocyte Depletion in Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Fluge Ø; Rekeland IG; Lien K; Thürmer H; Borchgrevink PC; Schäfer C; Sørland K; Aßmus J; Ktoridou-Valen I; Herder I; Gotaas ME; Kvammen Ø; Baranowska KA; Bohnen LMLJ; Martinsen SS; Lonar AE; Solvang AH; Gya AES; Bruland O; Risa K; Alme K; Dahl O; Mella O
    Ann Intern Med; 2019 May; 170(9):585-593. PubMed ID: 30934066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health-related quality of life in patients with myalgic encephalomyelitis/chronic fatigue syndrome: an Australian cross-sectional study.
    Eaton-Fitch N; Johnston SC; Zalewski P; Staines D; Marshall-Gradisnik S
    Qual Life Res; 2020 Jun; 29(6):1521-1531. PubMed ID: 31970624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose naltrexone for post-COVID fatigue syndrome: a study protocol for a double-blind, randomised trial in British Columbia.
    Naik H; Cooke E; Boulter T; Dyer R; Bone JN; Tsai M; Cristobal J; McKay RJ; Song X; Nacul L
    BMJ Open; 2024 May; 14(5):e085272. PubMed ID: 38740499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychometric properties of the PROMIS
    Yang M; Keller S; Lin JS
    Qual Life Res; 2019 Dec; 28(12):3375-3384. PubMed ID: 31506915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A systematic review of nutraceutical interventions for mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndrome.
    Maksoud R; Balinas C; Holden S; Cabanas H; Staines D; Marshall-Gradisnik S
    J Transl Med; 2021 Feb; 19(1):81. PubMed ID: 33596913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.